The use of non-prion biomarkers for the diagnosis of Transmissible Spongiform Encephalopathies in the live animal

Veterinary Research

Volumn 36, Issue 5-6, 2005, Pages 665-683

  Parveen, Ifat ^a   Moorby, Jon ^a   Allison, Gordon ^a   Jackman, Roy ^b  

^a ABERYSTWYTH UNIVERSITY   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

BSE; Diagnostic; Non prion markers; Scrapie; vCJD

Indexed keywords

ACTIVIN A; APOLIPOPROTEIN E; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CORTISONE; CYSTATIN C; ESTRADIOL; FATTY ACID BINDING PROTEIN; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; INTERLEUKIN 6; NEURON SPECIFIC ENOLASE; PRION PROTEIN; PROGESTERONE; PROLACTIN; PROSTAGLANDIN E2; PROTEIN 14 3 3; PROTEIN PRIONIN; PROTEIN S100B; TAU PROTEIN; UNCLASSIFIED DRUG; UREA;

ALZHEIMER DISEASE; ANTIGEN EXPRESSION; BLOOD ANALYSIS; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN SPONGIOSIS; CEREBROSPINAL FLUID ANALYSIS; CORTICOSTEROID BLOOD LEVEL; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DISEASE MARKER; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; HEART RATE VARIABILITY; HUMAN; IATROGENIC DISEASE; IMMUNE RESPONSE; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MULTIINFARCT DEMENTIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRION; PRION DISEASE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RETICULOENDOTHELIAL SYSTEM; REVIEW; SCRAPIE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ANIMALS; BIOLOGICAL MARKERS; HUMANS; NERVE TISSUE PROTEINS; PRION DISEASES;

ANIMALIA; BOVINAE; OVIS ARIES;

EID: 24944527439     PISSN: 09284249     EISSN: None     Source Type: Journal    
DOI: 10.1051/vetres:2005028     Document Type: Review

References (130)

1. Aguzzi A., Blood simple prion diagnostics, Nat. Med. 7 (2001) 289-290.
2. Aksamit A.J.J., Preissner C.M., Homburger H.A., Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease, Neurology 57 (2001) 728-730.
3. Anderson R.M., Donnelly C.A., Ferguson N.M., Woolhouse M.E.J., Watt C.J., Udy H.J., MaWhinney S., Dunstan S.P., Southwood T.R.E., Wilesmith J.W., Ryan J.B.M., Hoinville L.J., Hillerton J.E., Austin A.R., Wells G.A.H., Transmission dynamics and epidemiology of BSE: in British cattle, Nature 382 (1996) 779-788.
4. Sc in gut-associated lymphoid and nervous tissues of susceptible sheep from a Romanov flock with natural scrapie, J. Gen. Virol. 81 (2000) 3115-3126.
5. Austin A.R., Meek S., Webster S., Pomfrett C.J.D., Heart rate variability in BSE, Vet. Rec. 139 (1996) 631.
6. Barbuddhe S.B., Malik S.V.S., Choudhary S.P., Gupta L.K., Kinetics of interferon-gamma production and its comparison with anti-listeriolysin O detection in experimental bovine listeriosis, Vet. Res. Commun. 22 (1998) 505-516.
7. Beaudry P., Cohen P., Brandel J.P., Delasnerie-Laupretre N., Richard S., Launay J.M., Laplanche J.L., 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease, Dement. Geriatr. Cogn. Disord. 10 (1999) 40-46.
8. Beck E., Parry H.B., Daniel P.M., Degeneration of cerebellar and hypothalamo-neurohypophysial systems in sheep with scrapie; and its relationship to human system degenerations, Brain 87 (1964) 153-176.
9. Beekes M., McBride P.A., Early accumulation of pathological PrP in the enteric nervous system and gut-associated lymphoid tissue of hamsters orally infected with scrapie, Neurosci. Lett. 278 (2000) 181-184.
10. Beekes M., McBride P.A., Baldauf E., Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie, J. Gen. Virol. 79 (1998) 601-607.
11. Beekes M., Otto M., Wiltfang J., Bahn E., Poser S., Baier M., Late increase of serum S100 beta protein levels in hamsters after oral or intraperitoneal infection with scrapie, J. Infect. Dis. 180 (1999) 518-520.
12. Bellon A., Seyfert-Brandt W., Lang W., Baron H., Groner A., Vey M., Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity, J. Gen. Virol. 84 (2003) 1921-1925.
13. Bennion B.J., Daggett V., Protein conformation and diagnostic tests: The prion protein, Clin. Chem. 48 (2002) 2105-2114.
14. Bodemer W., Kaup F.J., Comments on present-day spread and epidemiology of BSE and prion diseases, Gesundheitswesen 66 Suppl. 1 (2004) 821-825.
15. Brenig B., Schütz E., Urnovitz H., Cellular nucleic acids in serum and plasma as new diagnostic tools, Berl. Munch. Tierarztl. Wochenschr. 115 (2002) 122-124.
16. Brown P., The phantasmagoric immunology of transmissible spongiform encephalopathy, Res. Publ. Assoc. Res. Nerv. Ment. Dis. 68 (1990) 305-313.
17. Brown P., Rohwer R.G., Dunstan B.C., MacAuley C., Gajdusek D.C., Drohan W.N., The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy, Transfusion 38 (1998) 810-816.
18. Brown P., Cervenakova L., Diringer H., Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease, J. Lab. Clin. Med. 137 (2001) 5-13.
19. Carp R.I., Kim Y.S., Callahan S.M., Scrapie-induced alterations in glucose-tolerance in mice, J. Gen. Virol. 70 (1989) 827-835.
20. Carp R.I., Kim Y.S., Callahan S.M., Pancreatic lesions and hypoglycemia-hyperinsulinemia in scrapie-injected hamsters, J. Infect. Dis. 161 (1990) 462-466.
21. Carrette O., Demalte I., Scherl A., Yalkinoglu O., Corthals G., Burkhard P., Hochstrasser D.F., Sanchez J.C., A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease, Proteomics 3 (2003) 1486-1494.
22. Chandler R.L., Attempts to demonstrate antibodies in scrapie disease, Vet. Rec. 71 (1959) 58-59.
23. Choe L.H., Green A., Knight R.S.G., Thompson E.J., Lee K.H., Apolipoprotein E and other cerebrospinal fluid proteins differentiate ante mortem variant Creutzfeldt-Jakob disease from ante mortem sporadic Creutzfeldt-Jakob disease, Electrophoresis 23 (2002) 2242-2246.
24. Detwiler L.A., Baylis M., The epidemiology of scrapie, Rev. Sci. Tech. Off. Int. Epizoot. 22 (2003) 121-143.
25. Diaz F., Masso F., Paez A., Varela E., Suarez-Guemes F., Montano L.F., Secretion of IFN-gamma by bovine peripheral blood mononuclear cells stimulated with Mycobacterium bovis protein fractions obtained by isoelectric-focusing, Vet. Immunol. Immunopathol. 67 (1999) 203-212.
26. Diedrich J.F., Bendheim P.E., Kim Y.S., Carp R.I., Haase A.T., Scrapie-associated prion protein accumulates in astrocytes during scrapie infection, Proc. Natl. Acad. Sci. USA 88 (1991) 375-379.
27. Diedrich J.F., Minnigan H., Carp R.I., Whitaker J.N., Race R., Frey W., Haase A.T., Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein-E and cathepsin-D in astrocytes, J. Virol. 65 (1991) 4759-4768.
28. Finkenstaedt M., Szudra A., Zerr I., Poser S., Hise J.H., Stoebner J.M., Weber T., MR imaging of Creutzfeldt-Jakob disease, Radiology 199 (1996) 793-798.
29. Foster J.D., Parnham D.W., Hunter N., Bruce M., Distribution of the prion protein in sheep terminally affected with BSE following experimental oral transmission, J. Gen. Virol. 82 (2001) 2319-2326.
30. Fukuyama R., Izumoto T., Fushiki S., The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer's disease patients and correlates with severity of dementia, Eur. Neurol. 46 (2001) 35-38.
31. Furukawa H., Doh-ura K., Okuwaki R., Shirabe S., Yamamoto K., Udono H., Ito T., Katamine S., Niwa M., A pitfall in diagnosis of human prion diseases using detection of protease-resistant prion protein in urine - Contamination with bacterial outer membrane proteins, J. Biol. Chem. 279 (2004) 23661-23667.
32. Gauczynski S., Peyrin J.M., Haik S., Leucht C., Hundt C., Rieger R., Krasemann S., Deslys J.P., Dormont D., Lasmezas C.I., Weiss S., The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein, EMBO J. 20 (2001) 5863-5875.
33. Gayrard V., Picard-Hagen N., Grino M., Sauze N., Grandjean C., Galea J., Andreoletti O., Scheicher F., Toutain P.L., Major hypercorticism is an endocrine feature of ewes with naturally occurring scrapie, Endocrinology 141 (2000) 988-994.
34. Ghosh S., Mechanism of intestinal entry of infectious prion protein in the pathogenesis of variant Creutzfeldt-Jakob disease, Adv. Drug Deliv. Rev. 56 (2004) 915-920.
35. Giles J., Mad cow disease comes to Japan, Nature 413 (2001) 240-240.
36. Glock B., Winter M., Rennhofer S.O., Brunholzl E., Troscher D., Reisacher R.B.K., Mayr W.R., Transcript level of erythroid differentiation-related factor, a candidate surrogate marker for transmissible spongiform encephalopathy diseases in blood, shows a broad range of variation in healthy individuals, Transfusion 43 (2003) 1706-1710.
37. Godfroid J., Czaplicki G., Kerkhofs P., Weynants V., Wellemans G., Thiry E., Letesson J.J., Assessment of the cell-mediated immunity in cattle infection after bovine herpesvirus 4 infection, using an in vitro antigen-specific interferon-gamma assay, Vet. Microbiol. 53 (1996) 133-141.
38. Green A.J.E., Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease, Biochem. Soc. Trans. 30 (2002) 382-386.
39. Green A.J.E., Jackman R., Marshall T.A., Thompson E.J., Increased S-100b in the cerebrospinal fluid of some cattle with bovine spongiform encephalopathy, Vet. Rec. 145 (1999) 107-109.
40. Green A.J.E., Thompson E.J., Stewart G.E., Zeidler M., McKenzie J.M., MacLeod M.A., Ironside J.W., Will R.G., Knight R.S.G., Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease, J. Neurol. Neurosurg. Psychiatry 70 (2001) 744-748.
41. Guillaume E., Zimmermann C., Burkhard P.R., Hochstrasser D.F., Sanchez J.C., A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob disease, Proteomics 3 (2003) 1495-1499.
42. Heggebo R., Press C.M., Gunnes G., Lie K.I., Tranulis M.A., Ulvund M., Groschup M.H., Landsverk T., Distribution of prion protein in the ileal Peyer's patch of scrapie-free lambs and lambs naturally and experimentally exposed to the scrapie agent, J. Gen. Virol. 81 (2000) 2327-2337.
43. Heppner F.L., Arrighi I., Kalinke U., Aguzzi A., Immunity against prions? Trends Mol. Med. 7 (2001) 477-479.
44. Hochstrasser D.F., Frutiger S., Wilkins M.R., Hughes G., Sanchez J.C., Elevation of apolipoprotein E in the CSF of cattle affected by BSE, FEBS Lett. 416 (1997) 161-163.
45. Holtzman D.M., Pitas R.E., Kilbridge J., Nathan B., Mahley R.W., Bu G.J., Schwartz A.L., Low-density-lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell-line, Proc. Natl. Acad. Sci. USA 92 (1995) 9480-9484.
46. Horiuchi M., Caughey B., Prionprotein interconversions and the transmissible spongiform encephalopathies, Structure Fold. Des. 7 (1999) R231-R240.
47. Houston F., Foster J.D., Chong A., Hunter N., Bostock C.J., Transmission of BSE by blood transfusion in sheep, Lancet 356 (2000) 999-1000.
48. Hundt C., Peyrin J.M., Haik S., Gauczynski S., Leucht C., Rieger R., Riley M.L., Deslys J.P., Dormont D., Lasmezas C.I., Weiss S., Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor, EMBO J. 20 (2001) 5876-5886.
49. Hunter N., Foster J., Chong A., McCutcheon S., Parnham D., Eaton S., MacKenzie C., Houston F., Transmission of prion diseases by blood transfusion, J. Gen. Virol. 83 (2002) 2897-2905.
50. Ironside J.W., Head M.W., Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products, Haemophilia 10 (2004) 64-69.
51. Itoh N., Arai H., Urakami K., Ishiguro K., Ohno H., Hampel H., Buerger K., Wiltfang J., Otto M., Kretzschmar H., Moeller H.J., Imagawa M., Kohno H., Nakashima K., Kuzuhara S., Sasaki H., Imahori K., Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease, Ann. Neurol. 50 (2001) 150-156.
52. Jones V., Martin T.C., Keyes P., Dawson M., Protein markers in cerebrospinal fluid from BSE-affected cattle, Vet. Rec. 139 (1996) 360-363.
53. Kellar J.A., Lees V.W., Risk management of the transmissible spongiform encephalopathies in North America, Rev. Sci. Tech. Off. Int. Epizoot. 22 (2003) 201-225.
54. Kneipp J., Lasch P., Baldauf E., Beekes M., Naumann D., Detection of pathological molecular alterations in scrapie- infected hamster brain by Fourier transform infrared (FT-IR) spectroscopy, Biochim. Biophys. Acta 1501 (2000) 189-199.
55. Kneipp J., Beekes M., Lasch P., Naumann D., Molecular changes of preclinical scrapie can be detected by infrared spectroscopy, J. Neurosci. 22 (2002) 2989-2997.
56. Kneipp J., Miller L.M., Joncic M., Kittel M., Lasch P., Beekes M., Naumann D., In situ identification of protein structural changes in prion-infected tissue, Biochim. Biophys. Acta 1639 (2003) 152-158.
57. Kordek R., Liberski P.P., Yanagihara R., Isaacson S., Gajdusek D.C., Molecular analysis of prion protein (PrP) and glial fibrillary acidic protein (GFAP) transcripts in experimental Creutzfeldt-Jakob disease in mice, Acta Neurobiol. Exp. 57 (1997) 85-90.
58. Kubler E., Oesch B., Alex J.R., Diagnosis of prion diseases, Br. Med. Bull. 66 (2003) 267-279.
59. Lasch P., Schmitt J., Beekes M., Udelhoven T., Eiden M., Fabian H., Petrich W., Naumann D., Antemortem identification of bovine spongiform encephalopathy from serum using infrared spectroscopy, Anal. Chem. 75 (2003) 6673-6678.
60. Lazarini F., Castelnau P., Chermann J.F., Deslys J.P., Dormont D., Modulation of prion protein gene-expression by growth-factors in cultured mouse astrocytes and Pc12 Cells, Mol. Brain Res. 22 (1994) 268-274.
61. Lee K.H., Harrington M.G., 14-3-3 and BSE, Vet. Rec. 140 (1997) 206-207.
62. McBride P.A., Beekes M., Pathological PrP is abundant in sympathetic and sensory ganglia of hamsters fed with scrapie, Neurosci. Lett. 265 (1999) 135-138.
63. McBride P.A., Schulz-Schaeffer W.J., Donaldson M., Bruce M., Diringer H., Kretzschmar H.A., Beekes M., Early spread of scrapie from the gastrointestinal tract to the central nervous system involves autonomic fibers of the splanchnic and vagus nerves, J. Virol. 75 (2001) 9320-9327.
64. Miele G., Manson J., Clinton M., A novel erythroid-specific marker of transmissible spongiform encephalopathies, Nat. Med. 7 (2001) 361-364.
65. Minghetti L., Greco A., Cardone F., Puopolo M., Ladogana A., Almonti S., Cunningham C., Perry V.H., Pocchiari M., Levi G., Increased brain synthesis of prostaglandin E-2 and F-2-isoprostane in human and experimental transmissible spongiform encephalopathies, J. Neuropathol. Exp. Neurol. 59 (2000) 866-871.
66. Missler U., Wiesmann M., Wittmann G., Magerkurth O., Hagenstrom H., Measurement of glial fibrillary acidic protein in human blood: Analytical method and preliminary clinical results, Clin. Chem. 45 (1999) 138-141.
67. Moorby J.M., Dhanoa M.S., Austin A.R., Aspects of the metabolism of dairy cows during the incubation of bovine spongiform encephalopathy, Vet. Rec. 147 (2000) 409-412.
68. Moorby J.M., Begley P., Nash R.J., Theodorou M.K., Austin A.R., Plasma metabolites indicate energy metabolism disruption during the preclinical phase of bovine spongiform encephalopathy infection, Res. Vet. Sci. 73 (2002) 191-193.
69. Moynagh J., Schimmel H., Tests for BSE evaluated, Nature 400 (1999) 105-105.
70. Murphy C., Breen C, Rogers M., Giese M., Interferon gamma and prostaglandin in BSE-infected cattle, Cytokine 13 (2001) 169-173.
71. Neill S.D., Cassidy J., Hanna J., Mackie D.P., Pollock J.M., Clements A., Walton E., Bryson D.G., Detection of Mycobacterium bovis infection in skin test-negative cattle with an assay for bovine interferon-gamma, Vet. Rec. 135 (1994) 134-135.
72. Nunnally B.K., It's a mad, mad, mad, mad cow: a review of analytical methodology for detecting BSE /TSE, Trends Analyt. Chem. 21 (2002) 82-89.
73. Otto M., Wiltfang J., Differential diagnosis of neurodegenerative diseases with special emphasis on Creutzfeldt-Jakob disease, Restor. Neurol. Neurosci. 21 (2003) 191-209.
74. Otto M., Stein H., Szudra A., Zerr I., Bodemer M., Gefeller O., Poser S., Kretzschmar H.A., Mader M., Weber T., S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease, J. Neurol. 244 (1997) 566-570.
75. Otto M., Wiltfang J., Tumani H., Zerr I., Lantsch M., Kornhuber J., Weber T., Kretzschmar H.A., Poser S., Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease, Neurosci. Lett. 225 (1997) 210-212.
76. Otto M., Beekes M., Wiltfang J., Bahn E., Poser S., Diringer H., Elevated levels of serum S100 beta protein in scrapie hamsters, J. Neurovirol. 4 (1998) 572-573.
77. Otto M., Wiltfang J., Schutz E., Zerr I., Otto A., Pfahlberg A., Gefeller O., Uhr M., Giese A., Weber T., Kretzschmar H.A., Poser S., Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study, BMJ 316 (1998) 577-582.
78. Otto M., Wiltfang J., Cepek L., Neumann M., Mollenhauer B., Steinacker P., Ciesielezyk B., Schulz-Schaeffer W., Kretzschmar H.A., Poser S., Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease, Neurology 58 (2002) 192-197.
79. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z.W., Fletterick R.J., Cohen F.E., Prusiner S.B., Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins, Proc. Natl. Acad. Sci. USA 90 (1993) 10962-10966.
80. Parnigotto P.P., Conconi M.T., Effects of prostaglandin E-2 on growth, morphology, morphometry and keratin pattern of bovine corneal epithelial cells cultured in vitro, Anat. Anz. 180 (1998) 511-518.
81. Peden A.H., Head M.W., Ritchie D.L., Bell J.E., Ironside J.W., Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient, Lancet 364 (2004) 527-529.
82. Picard-Hagen N., Gayrard V., Andreoletti O., Galea J., Grandjean C., Mandon-Maurice F., Cabanie P., Scheicher F., Toutain P.L., Melatonin and prolactin secretion profile in naturally occurring scrapie in ewe, J. Pineal Res. 24 (1998) 117-122.
83. Picard-Hagen N., Gayrard V., Laroute V., Grandjean C., Andreoletti O., Elsen J.M., Schelcher F., Toutain P.L., Discriminant value of blood and urinary corticoids for the diagnosis of scrapie in live sheep, Vet. Rec. 150 (2002) 680-684.
84. Pomfrett C.J.D., Austin A.R., Bovine spongiform encephalopathy (BSE) disrupts heart rate variability (HRV), J. Physiol. London 501P (1997) P69-P69.
85. Pomfrett C.J.D., Glover D.G., Bollen B.G., Pollard B.J., Perturbation of heart rate variability in cattle fed BSE- infected material, Vet. Rec. 154 (2004) 687-691.
86. Porges S.W., Orienting in a defensive world - mammalian modifications of our evolutionary heritage - a Polyvagal theory, Psychophysiology 32 (1995) 301-318.
87. Portaluppi F., Cortelli P., Avoni P., Vergnani L., Contin M., Maltoni P., Pavani A., Sforza E., Uberti E.C.D., Gambetti P., Lugaresi E., Diurnal blood-pressure variation and hormonal correlates in Fatal Familial Insomnia, Hypertension 23 (1994) 569-576.
88. Prusiner S.B., Molecular Biology of Prion Diseases, Science 252 (1991) 1515-1522.
89. Prusiner S.B., Prion diseases and the BSE crisis, Science 278 (1997) 245-251.
90. Prusiner S.B., The prion diseases, Brain Pathol. 8 (1998) 499-513.
91. Raabe A., Grolms C., Seifert V., Serum markers of brain damage and outcome prediction in patients after severe head injury, Br. J. Neurosurg. 13 (1999) 56-59.
92. Rieger R.E.F., Lasmezas C.I., Weiss S., The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells, Nat. Med. 3 (1997) 1383-1388.
93. Riemer C., Queck I., Simon D., Kurth R., Baier M., Identification of upregulated genes in scrapie-infected brain tissue, J. Virol. 74 (2000) 10245-10248.
94. Riond J.L., Hartmann P., Joller-Jemelka H.I., Braun U., S-100 and bovine spongiform encephalopathy, Vet. Rec. 145 (1999) 114-115.
95. Robey W.G., Jackson R., Walters R.L., Brackett J.M., Harrington C.A., Killian W.R., Use of cerebrospinal fluid levels of 14-3-3 in predicting neurodegeneration in confirmed BSE symptomatic cattle, Vet. Rec. 143 (1998) 50-51.
96. Roesler J., Kofink B., Wendisch J., Heyden S., Paul D., Friedrich W., Casanova J.L., Leupold W., Gahr M., Rosen-Wolff A., Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma- receptor (IFN gamma R1) deficiency: Mutational analysis and evaluation of therapeutic options, Exp. Hematol. 27 (1999) 1368-1374.
97. Ruth L., The quest for new prion tests, Anal. Chem. 75 (2003) 32A-36A.
98. Safar J.G., Scott M., Monaghan J., Deering C., Didorenko S., Vergara J., Ball H., Legname G., Leclerc E., Solforosi L., Serban H., Groth D., Burton D.R., Prusiner S.B., Williamson R.A., Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice, Nat. Biotechnol. 20 (2002) 1147-1150.
99. Sanchez J.C., Guillaume E., Lescuyer P., Allard L., Carrette O., Scherl A., Burgess J., Corthals G.L., Burkhard P.R., Hochstrasser D.F., Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease. Proteomics 4 (2004) 2229-2233.
100. Sayer N.M., Cubin M., Rhie A., Bullock M., Tahiti-Alaoui A., James W., Structural determinants of conformationally selective, prion-binding aptamers, J. Biol. Chem. 279 (2004) 13102-13109.
101. Sc detection and its use as a rapid surveillance method for the diagnosis of bovine spongiform encephalopathy (BSE), Acta Neuropathol. 98 (1999) 437-443.
102. Schein C.H., Haugg M., Banner S.A., Interferon-gamma activates the cleavage of double-stranded-RNA by bovine seminal ribonuclease, FEBS Lett. 270 (1990) 229-232.
103. Scheicher F., Picard-Hagen N., Laroute V., Gayrard V., Popot M.A., Andreoletti O., Toutain P.L., Corticoid concentrations are increased in the plasma and urine of ewes with naturally occurring scrapie, Endocrinology 140 (1999) 2422-2425.
104. Schiermeier Q., Testing times for BSE, Nature 409 (2001) 658-659.
105. Schmerr M.J., Jenny A.L., Bulgin M.S., Miller J.M., Hamir A.N., Cutlip R.C., Goodwin K.R., Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy, J. Chromatogr. A 853 (1999) 207-214.
106. Schmitt J., Beekes M., Brauer A., Udelhoven T., Lasch P., Naumann D., Identification of scrapie infection from blood serum by Fourier transform infrared spectroscopy, Anal. Chem. 74 (2002) 3865-3868.
107. Schroter A., Zerr I., Henkel K., Tschampa H.J., Finkenstaedt M., Poser S., Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease, Arch. Neurol. 57 (2000) 1751-1757.
108. Shaked G.M., Shaked Y., Kariv-Inbal Z., Halimi M., Avraham I., Gabizon R., A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases, J. Biol. Chem. 276 (2001) 31479-31482.
109. Sigurdson C.J., Spraker T.R., Miller M.W., Oesch B., Hoover E.A., PrPCWD in the myenteric plexus, vagosympathetic trunk and endocrine glands of deer with chronic wasting disease, J. Gen. Virol. 82 (2001) 2327-2334.
110. Sjögren M., EDRF transcripts and diagnosis of variant Creutzfeldt-Jakob disease, Lancet 357 (2001) 2069-2070.
111. Steinhoff B.J., Racker S., Herrendorf G., Poser S., Grosche S., Zerr I., Kretzschmar H., Weber T., Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease, Arch. Neurol. 53 (1996) 162-166.
112. Thomzig A.S.S., Friedrich M., Naumann D., Beekes M., Discriminating scrapie and bovine spongiform encephalopathy isolates by infrared spectroscopy of pathological prion protein, J. Biol. Chem. 279 (2004) 33847-33854.
113. Tyler J.W., Lakritz J., Weaver D., Johnson G., VanMetre D., Smith K., Taylor W., Jenny A., The 14-3-3 cerebrospinal fluid immunoassay lacks utility in the diagnosis of clinical scrapie, J. Vet. Diagn. Invest. 13 (2001) 537-539.
114. Van Everbroeck B., Green A.J.E., Vanmechelen E., Vanderstichele H., Pals P., Sanchez-Valle R., Corrales N.C., Martin J.J., Cras P., Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt-Jakob disease, J. Neurol. Neurosurg. Psychiatry 73 (2002) 79-81.
115. Van Keulen L.J., Schreuder B.E., Vromans M.E., Langeveld J.P., Smits M.A., Pathogenesis of natural scrapie in sheep, Arch. Virol. Suppl. 16 (2000) 57-71.
116. Van Keulen L.J.M., Vromans M.E.W., Van Zijderveld F.G., Early and late pathogenesis of natural scrapie infection in sheep, APMIS 110 (2002) 23-32.
117. Verbeek M.M., de Jong D., Kremer H.P.H., Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases, Ann. Clin. Biochem. 40 (2003) 25-40.
118. Viguié C., Chilliard Y., Gayrard V., Picard-Hagen N., Monget P., Dutour A., Toutain P.L., Alterations of somatotropic function in prion disease in sheep, J. Endocrinol. 183 (2004) 427-435.
119. Völkel D., Zimmermann K., Zerr I., Bodemer M., Lindner T., Turecek P.L., Poser S., Schwarz H.P., Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases, Transfusion 41 (2001) 441-448.
120. Völkel D., Zimmermann K., Zerr I., Lindner T., Bodemer M., Poser S., Schwarz H.P., C-reactive protein and IL-6: new marker proteins for the diagnosis of CJD in plasma? Transfusion 41 (2001) 1509-1514.
121. Wedlock D.N., Aldwell F.E., Collins D.M., de Lisle G.W., Wilson T., Buddle B.M., Immune responses induced in cattle by virulent and attenuated Mycobacterium bovis strains: Correlation of delayed-type hypersensitivity with ability of strains to grow in macrophages, Infect. Immun. 67 (1999) 2172-2177.
122. Wells G.A.H., Hancock R.D., Cooley W.A., Richards M.S., Higgins R.J., David G.P., Bovine spongiform encephalopathy - diagnostic-significance of vacuolar changes in selected nuclei of the medulla-oblongata, Vet. Rec. 125 (1989) 521-524.
123. Will R.G., Ironside J.W., Zeidler M., Cousens S.N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofman A., Smith P.G., A new variant of Creutzfeldt-Jakob disease in the UK, Lancet 347 (1996) 921-925.
124. Wille H., Michelitsch M.D., Guenebaut V., Supattapone S., Serban A., Cohen F.E., Agard D.A., Prusiner S.B., Structural studies of the scrapie priori protein by electron crystallography, Proc. Natl. Acad. Sci. USA 99 (2002) 3563-3568.
125. Woolfson L.A.M., Glover D.G., Pollard B.J., Pomfrett C.J.D., Symptomatic vCJD alters heart rate variability, J. Physiol. 551P (2003) C47.
126. Xiang W., Windl O., Wünsch G., Dugas M., Kohlmann A., Dierkes N., Westner I.M., Kretzschmar H.A., Identification of differentially expressed genes in scrapie- infected mouse brains by using global gene expression technology, J. Virol. 78 (2004) 11051-11060.
127. Yamada M., Cerebral amyloid angiopathy: An overview, Neuropathology 20 (2000) 8-22.
128. Ye X., Carp R.I., Histopathological changes in the pituitary glands of female hamsters infected with the 139H strain of scrapie, J. Comp. Pathol. 114 (1996) 291-304.
129. Zeidler M., Sellar R.J., Collie D.A., Knight R., Stewart G., Macleod M.A., Ironside J.W., Cousens S., Colchester A.F.C., Hadley D.M., Will R.G., The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease, Lancet 355 (2000) 1412-1418.
130. Zerr I., Bodemer M., Racker S., Grosche S., Poser S., Kretzschmar H.A., Weber T., Cerebrospinal-fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease, Lancet 345 (1995) 1609-1610.